Hippocampal damage in mouse and human forms of systemic autoimmune disease

Hippocampus

Volumn 14, Issue 5, 2004, Pages 649-661

  Ballok, David A ^a   Woulfe, John ^d   Sur, Monalisa ^c   Cyr, Michael ^c   Sakic, Boris ^a,b,c  

^a Dept of Psychiat/Behav Neurosci ^*  (Canada)

^b Brain Body Institute   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Autoimmunity; Cyclophosphamide; Fluro Jade B; Hippocampus; Inflammation; Lupus; MRL mice; Spontaneous alternation behavior; Ubiquitin

Indexed keywords

CYCLOPHOSPHAMIDE; FLUORESCENT DYE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; UBIQUITIN;

ADULT; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BEHAVIOR DISORDER; BRAIN CALCIFICATION; BRAIN DYSFUNCTION; BRAIN NERVE CELL; CASE REPORT; CELL DENSITY; CHOROID PLEXUS; COGNITIVE DEFECT; CONTROLLED STUDY; DENTATE GYRUS; DISEASE SEVERITY; FEMALE; GLIOSIS; GRAY MATTER; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEARNING DISORDER; MALE; MOOD DISORDER; MOUSE; NEUROPATHOLOGY; NEUROPSYCHIATRY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TASK PERFORMANCE;

AGING; ANIMALS; ANTIGENS, CD95; CHOROID PLEXUS; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; FEMALE; FLUORESCENT DYES; GLIOSIS; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; LEARNING DISORDERS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; MAZE LEARNING; MEMORY DISORDERS; MICE; MICE, INBRED MRL LPR; MIDDLE AGED; NERVE DEGENERATION; NEURONS; ORGANIC CHEMICALS; T-LYMPHOCYTES;

EID: 3042599416     PISSN: 10509631     EISSN: None     Source Type: Journal    
DOI: 10.1002/hipo.10205     Document Type: Review

References (90)

1. Alexander EL, Murphy ED, Roths JB, Alexander GE. 1983. Congenic autoimmune murine models of central nervous system disease in connective tissue disorders. Ann Neurol 14:242-248.
2. Alves-Rodrigues A, Gregori L, Figueiredo-Pereira ME. 1998. Ubiquitin, cellular inclusions and their role in neurodegeneration. Trends Neurosci 21:516-520.
3. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, McConahey PJ, Murphy ED, Roths JB, Dixon FJ. 1978. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains. J Exp Med 148:1198-1215.
4. Armanini MP, Hutchins C, Stein BA, Sapolsky RM. 1990. Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent. Brain Res 532:7-12.
5. Atkins CJ, Kondon JJ, Quismorio FP, Friou GJ. 1972. The choroid plexus in systemic lupus erythematosus. Ann Intern Med 76:65-72.
6. Ballok DA, Millward JM, Sakic B. 2003. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining. Brain Res 964:200-210.
7. Bats S, Thoumas JL, Lordi B, Tonon MC, Lalonde R, Caston J. 2001. The effects of a mild stressor on spontaneous alternation in mice. Behav Brain Res 118:11-15.
8. Bertholet JY, Crusio WE. 1991. Spatial and non-spatial spontaneous alternation and hippocampal mossy fibre distribution in nine inbred mouse strains. Behav Brain Res 43:197-202.
9. Boumpas DT, Yamada H, Patronas NJ, Scott D, Klippel JH, Balow JE. 1991. Pulse cyclophosphamide for severe neuropsychiatric lupus. Q J Med 81:975-984.
10. Brooks WM, Sabet A, Sibbitt WL Jr, Barker PB, van Zijl PC, Duyn JH, Moonen CT. 1997. Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. J Rheumatol 24:2323-2329.
11. Bruyn GAW. 1995. Controversies in lupus: nervous system involvement. Ann Rheum Dis 54:159-167.
12. Carbotte RM, Denburg SD, Denburg JA. 1995. Cognitive dysfunction in systemic lupus erythematosus is independent of active disease. J Rheumatol 22:863-867.
13. Chinn RJS, Wilkinson ID, Hallcraggs MA, Paley MNJ, Shorthall E, Carter S, Kendall BE, Isenberg DA, Newman SP, Harrison MJG. 1997. Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. Arthritis Rheum 40:36-46.
14. Crimando J, Hoffman SA. 1992. Detection of brain-reactive autoantibodies in the sera of autoimmune mice using ELISA. J Immunol Methods 149:87-95.
15. Crimando J, Hoffman SA. 1995. Characterization of murine brain-reactive monoclonal IgG autoantibodies. Brain Behav Immun 9:165-181.
16. Deacon RM, Bannerman DM, Kirby BP, Croucher A, Rawlins JN. 2002. Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery. Behav Brain Res 133:57-68.
17. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. 2001. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 7:1189-1193.
18. DeKosky ST, Scheff SW. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity. Ann Neurol 27:457-464.
19. Denenberg VH, Sherman GF, Rosen GD, Morrison L, Behan PO, Galaburda AM. 1992. A behavior profile of the MRL/Mp lpr/lpr mouse and its association with hydrocephalus. Brain Behav Immun 6:40-49.
20. Denburg SD, Carbotte RM, Denburg JA. 1997. Psychological aspects of systemic lupus erythematosus: cognitive function, mood, and self-report. J Rheumatol 24:998-1003.
21. Duprez T, Nzeusseu A, Peeters A, Houssiau FA. 2001. Selective involvement of the choroid plexus on cerebral magnetic resonance images: a new radiological sign in patients with systemic lupus erythematosus with neurological symptoms. J Rheumatol 28:387-391.
22. Elouaai F, Lule J, Benoist H, Appolinaire-Pilipenko S, Atanassov C, Muller S, Fournie GJ. 1994. Autoimmunity to histones, ubiquitin, and ubiquitinated histone H2A in NZB × NZW and MRL-lpr/lpr mice. Anti-histone antibodies are concentrated in glomerular eluates of lupus mice. Nephrol Dial Transplant 9:362-366.
23. Farrell M, Sakic B, Szechtman H, Denburg JA. 1997. Effect of cyclophosphamide on leucocytic infiltration in the brain of MRL/lpr mice. Lupus 6:268-274.
24. Gerlai R. 2001. Behavioral tests of hippocampal function: simple paradigms, complex problems. Behav Brain Res 125:269-277.
25. Gershwin ME, Hyman LR, Steinberg AD. 1975. The choroid plexus in CNS involvement of systemic lupus erythematosus. J Pediatr 87:588-590.
26. Gray DA, Tsirigotis M, Woulfe J. 2003. Ubiquitin, proteasomes, and the aging brain. SAGE KE 34:1-6.
27. Grota LJ, Schachtman TR, Moynihan JA, Cohen N, Ader R. 1989. Voluntary consumption of cyclophosphamide by Mrl mice. Brain Behav Immun 3:263-273.
28. Grota LJ, Ader R, Moynihan JA, Cohen N. 1990. Voluntary consumption of cyclophosphamide by nondeprived Mrl- lpr/lpr and Mrl +/+ mice. Pharm Biochem Behav 37:527-530.
29. Hanly JG, Hong C, Smith S, Fisk JD. 1999. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 42:728-734.
30. Henn FA, McKinney WT. 1987. Animal models in psychiatry. In: Meltzer HY, editor. Psychopharmacology: the third generation of progress. New York: Raven Press. p 687-695.
31. Hess DC, Taormina M, Thompson J, Sethi KD, Diamond B, Rao R, Feldman DS. 1993. Cognitive and neurologic deficits in the MRL/lpr mouse: a clinicopathologic study. J Rheumatol 20:610-617.
32. Hickey WF, Lassmann S, Cross AH. 1997. Lymphocyte entry and the initiation of inflammation in the central nervous system. In: Keane RW, Hickey WF, editors. Immunology of the nervous system. New York: Oxford University Press. p 200-225.
33. Hoffman SA, Madsen CS. 1990. Brain specific autoantibodies in murine models of systemic lupus erythematosus. J Neuroimmunol 30:229-237.
34. Hopkins KJ, Wang G, Schmued LC. 2000. Temporal progression of kainic acid induced neuronal and myelin degeneration in the rat forebrain. Brain Res 864:69-80.
35. Hu Y, Dietrich H, Herold M, Heinrich PC, Wick G. 1993. Disturbed immuno-endocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune disease. Int Arch Allergy Immunol 102: 232-241.
36. Ioannou Y, Isenberg DA. 2002. Current concepts for the management of systemic lupus erythematosus in adults: a therapeutic challenge. Postgrad Med J 78:599-606.
37. Jentsch S, McGrath JP, Varshavsky A. 1987. The yeast DNA repair gene RAD6 encodes a ubiquitin-conjugating enzyme. Nature 329:131-134.
38. Khin NA, Hoffman SA. 1993. Brain reactive monoclonal auto-antibodies: production and characterization. J Neuroimmunol 44:137-148.
39. Kier AB. 1990. Clinical neurology and brain histopathology in NZB/ NZW F1 lupus mice. J Comp Pathol 102:165-177.
40. Kovac AD, Grammig J, Mahlo J, Steiner B, Roth K, Nitsch R, Bechmann I. 2002. Comparison of neuronal density and subfield sizes in the hippocampus of CD95L-deficient (gld), CD95-deficient (lpr) and nondeficient mice. Eur J Neurosci 16:159-163.
41. Lalonde R. 2002. The neurobiological basis of spontaneous alternation. Neurosci Biobehav Rev 26:91-104.
42. Lampert PW, Oldstone MB. 1973. Host immunoglobulin G and complement deposits in the choroid plexus during spontaneous immune complex disease. Science 180:408-410.
43. Lechner O, Dietrich H, Oliveira dos SA, Wiegers GJ, Schwarz S, Harbutz M, Herold M, Wick G. 2000. Altered circadian rhythms of the stress hormone and melatonin response in lupus-prone MRL/MP-fas(lpr) mice. J Autoimmun 14:325-333.
44. Magarinos AM, Verdugo JM, McEwen BS. 1997. Chronic stress alters synaptic terminal structure in hippocampus. Proc Natl Acad Sci USA 94:14002-14008.
45. Maric D, Millward JM, Ballok DA, Szechtman H, Barker JL, Denburg JA, Sakic B. 2001. Neurotoxic properties of cerebrospinal fluid from behaviorally impaired autoimmune mice. Brain Res 920:183-193.
46. McEwen BS, Gould EA, Sakai RR. 1992. The vulnerability of the hippocampus to protective and destructive effects of glucocorticoids in relation to stress. Br J Psychiatry Suppl: 18-23.
47. Muller S, Schwartz LM. 1995. Ubiquitin in homeostasis, development and disease. BioEssays 17:677-684.
48. Ng KT, Gibbs ME, Crowe SF, Sedman GL, Hua F, Zhao W, O'Dowd B, Rickard N, Gibbs CL, Sykova E. 1991. Molecular mechanisms of memory formation. Mol Neurobiol 5:333-350.
49. + T cell depletion on inflammatory central nervous system disease, arthritis and sialadenitis in MRL/lpr mice. J Autoimmun 8:163-175.
50. Park C, Sakamaki K, Tachibana O, Yamashima T, Yamashita J, Yonehara S. 1998. Expression of Fas antigen in the normal mouse brain. Biochem Biophys Res Commun 252:623-628.
51. Peress NS, Roxburgh VA, Gelfand MC. 1981. Binding sites for immune components in human choroid plexus. Arthritis Rheum 24:520-526.
52. Ramos PC, Mendez MJ, Ames PRJ, Khamashta MA, Hughes GRV. 1996. Pulse cyclophosphamide in the treatment of neuropsychiatric systemic lupus erythematosus. Clin Exp Rheumatol 14:295-299.
53. Richman CL, Dember WN, Kim P. 1986. Spontaneous alternation behavior in animals: a review. Curr Psychol Res Rev 5:358-391.
54. Roberts WW, Dember WN, Brodwick M. 1962. Alternation and exploration in rats with hippocampal lesions. J Comp Physiol Psychol 55: 695-700.
55. Roozendaal B, Phillips RG, Power AE, Brooke SM, Sapolsky RM, McGaugh JL. 2001. Memory retrieval impairment induced by hippocampal CA3 lesions is blocked by adrenocortical suppression. Nat Neurosci 4:1169-1171.
56. Sakic B, Szechtman H, Keffer M, Talangbayan H, Stead R, Denburg JA. 1992. A behavioral profile of autoimmune lupus-prone MRL mice. Brain Behav Immun 6:265-185.
57. Sakic B, Szechtman H, Denburg SD, Carbotte RM, Denburg JA. 1993. Spatial learning during the course of autoimmune disease in MRL mice. Behav Brain Res 54:57-66.
58. Sakic B, Szechtman H, Talangbayan H, Denburg SD, Carbotte RM, Denburg JA. 1994a. Behaviour and immune status of MRL mice in the postweaning period. Brain Behav Immun 8:1-13.
59. Sakic B, Szechtman H, Talangbayan H, Denburg SD, Carbotte RM, Denburg JA. 1994b. Disturbed emotionality in autoimmune MRL-lpr mice. Physiol Behav 56:609-617.
60. Sakic B, Szechtman H, Denburg SD, Denburg JA. 1995. Immunosuppressive treatment prevents behavioral deficit in autoimmune MRL-lpr mice. Physiol Behav 58:797-802.
61. Sakic B, Denburg JA, Denburg SD, Szechtman H. 1996. Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: a curve-shift study. Brain Res Bull 41:305-311.
62. Sakic B, Szechtman H, Denburg JA, Gorny G, Kolb B, Whishaw IQ. 1998. Progressive atrophy of pyramidal neuron dendrites in autoimmune MRL-lpr mice. J Neuroimmunol 87:162-170.
63. Sakic B, Kolb B, Whishaw IQ, Gorny G, Szechtman H, Denburg JA. 2000a. Immunosuppression prevents neuronal atrophy in lupus-prone mice: evidence for brain damage induced by autoimmune disease? J Neuroimmunol 111:93-101.
64. Sakic B, Maric I, Koeberle PD, Millward JM, Szechtman H, Maric D, Denburg JA. 2000b. Increased TUNEL-staining in brains of autoimmune Fas-deficient mice. J Neuroimmunol 104:147-154.
65. Sakic B, Lacosta S, Denburg J, Szechtman H. 2002. Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence. J Neuroimmunol 129:84-96.
66. Samuel W, Masliah E, Hill LR, Butters N, Terry R. 1994. Hippocampal connectivity and Alzheimer's dementia: effects of synapse loss and tangle frequency in a two-component model. Neurology 44:2081-2088.
67. Schmued LC, Hopkins KJ. 2000. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874:123-130.
68. Schnider A, Bassetti C, Gutbrod K, Ozdoba C. 1995. Very severe amnesia with acute onset after isolated hippocampal damage due to systemic lupus erythematosus. J Neurol Neurosurg Psychiatry 59:644-646.
69. Sherman GF, Morrison L, Rosen GD, Behan PO, Galaburda AM. 1990. Brain abnormalities in immune defective mice. Brain Res 532:25-33.
70. Shiraki M, Fujiwara M, Tomura S. 1984. Long term administration of cyclophosphamide in MRL/l mice. I. The effects on the development of immunological abnormalities and lupus nephritis. Clin Exp Immunol 55:333-339.
71. Sibbitt WL Jr, Sibbitt RR. 1993. Magnetic resonance spectroscopy and positron emission tomography scanning in neuropsychiatric systemic lupus erythematosus. Rheum Dis Clin North Am 19:851-868.
72. Snippe H, Davidse RP, Belder M, Willers JM. 1976. Effects of cyclophosphamide treatment on the in vitro activity of mouse lymphoid cells after nonspecific and specific stimulation. Int Arch Allergy Appl Immunol 50:536-547.
73. Sutherland RJ, McDonald RJ. 1990. Hippocampus, amygdala, and memory deficits in rats. Behav Brain Res 37:57-79.
74. Szechtman H, Sakic B, Denburg JA. 1997. Behaviour of MRL mice: an animal model of disturbed behaviour in systemic autoimmune disease. Lupus 6:223-229.
75. Tabatabaie T, Goyal RN, Blank CL, Dryhurst G. 1993. Further insights into the molecular mechanisms of action of the serotonergic neurotoxin 5,7-dihydroxytryptamine. J Med Chem 36:229-236.
76. Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T, Kishimoto T. 1991. Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol 3:273-278.
77. ten Berge RJ, van Walbeek HK, Schellekens PT. 1982. Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis. Clin Exp Immunol 50:495-502.
78. Theofilopoulos AN. 1992. Murine models of lupus. In: Lahita RG, editor. Systemic lupus erythematosus. New York: Churchill Livingstone. p 121-194.
79. Tomita M, Holman BJ, Santoro TJ. 2001. Aberrant cytokine gene expression in the hippocampus in murine systemic lupus erythematosus. Neurosci Lett 302:129-132.
80. Tsai CY, Wu TH, Huang SF, Sun KH, Hsieh SC, Han SH, Yu HS, Yu CL. 1995. Abnormal splenic and thymic IL-4 and TNF-alpha expression in MRL- lpr/lpr mice. Scand J Immunol 41:157-163.
81. Vogelweid CM, Johnson GC, Besch-Williford CL, Basler J, Walker SE. 1991. Inflammatory central nervous system disease in lupus-prone MRL/lpr mice: comparative histologic and immunohistochemical findings. J Neuroimmunol 35:89-99.
82. Walker SE. 2001. Bromocriptine treatment of systemic lupus erythematosus. Lupus 10:762-768.
83. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. 1992a. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314-317.
84. Watanabe-Fukunaga R, Brannan CI, Itoh N, Yonehara S, Copeland NG, Jenkins NA, Nagata S. 1992b. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J Immunol 148: 1274-1279.
85. Whishaw IQ. 1991. Latent learning in a swimming pool place task by rats: evidence for the use of associative and not cognitive mapping processes. Q J Exp Psychol B 43:83-103.
86. Wick G, Hu Y, Schwarz S, Kroemer G. 1993. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocr Rev 14:539-563.
87. Wood PL. 1998. Roles of CNS macrophages in neurodegeneration. In: Wood PL, editor. Neuroinflammation: mechanisms and management. Totowa, NJ: Humana Press. p 1-59.
88. Ye X, Carp RI, Schmued LC, Scallet AC. 2001. Fluoro-Jade and silver methods: application to the neuropathology of scrapie, a transmissible spongiform encephalopathy. Brain Res Brain Res Protoc 8:104-112.
89. Zalcman S, Greenjohnson JM, Murray L, Nance DM, Dyck D, Anisman H, Greenberg AH. 1994. Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6. Brain Res 643:40-49.
90. Zameer A, Hoffman SA. 2001. Immunoglobulin binding to brain in autoimmune mice. J Neuroimmunol 120:10-18.